IntelliPharmaCeutics International Inc. (IPCI) saw a big move last session, as the company’s shares fell by over 13% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading below the volatile price range of $3.63 to $4.15 in the past one-month time frame.
This slump shouldn’t be too much of a surprise to investors, as though the pharmaceutical company has seen no negative revision in the past few weeks, its current year earnings consensus has moved lower over the last 30 days. This suggests there may be more trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent slump will continue, as the earnings picture definitely suggests that this might be the case.
IPCI currently has a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Medical-Drugs industry include Synergy Pharmaceuticals, Inc. (SGYP), Aerie Pharmaceuticals, Inc. (AERI) and BioCryst Pharmaceuticals, Inc. (BCRX). Among these stocks, Synergy carries a Zacks Rank #1 (Strong Buy) and Aerie and BioCryst hold a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment